NBG-95389-47469 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-19
Dose 1 — Pfizer-BioNTech
2021-12-10
Dose 2 — Pfizer-BioNTech
2021-12-11
Registered in v-safe
2021-12-11
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Fair · Fever · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school

Adult check-in
2021-12-14
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Fair · Fatigue or tiredness, Abdominal pain

Adult check-in
2021-12-15
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-16
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-17
Health check-in — day 7, dose 2, dependent
Feeling: Good · Diarrhea

Adult check-in
2021-12-24
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2021-12-31
Survey response — day 21, dose 2, dependent
MedDRA: Rhinorrhoea — Feeling: Good

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-01-07
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-14
Survey response — day 35, dose 2, dependent
MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school

Free text: Fever for 24 hours

MedDRA releases: 2024-11 · check-in free text available
2022-01-21
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-03-11
Survey response — 3 months, dose 2, dependent
MedDRA: Conjunctivitis — Feeling: Fair

Free text: Pink eye

MedDRA releases: 2024-11 · check-in free text available
2022-06-10
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-12-13
Survey response — 12 months, dose 2, dependent
MedDRA: Cough, Nausea, Pyrexia, Respiratory disorder, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Had some sort of upper respiratory illness in the last two months - cough, congestion, intermittent nausea, fever

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-19	Pfizer-BioNTech	No
2	2021-12-10	Pfizer-BioNTech	No

Free text

Release 10 — day 21, dose 2, dependent

2021-12-31

Symptoms: Runny nose

Release 10 — day 35, dose 2, dependent

2022-01-14

Symptoms: Fever for 24 hours

Release 11 — 3 months, dose 2, dependent

2022-03-11

Symptoms: Pink eye

Release 12 — 12 months, dose 2, dependent

2022-12-13

Symptoms: Had some sort of upper respiratory illness in the last two months - cough, congestion, intermittent nausea, fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	Nausea	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory disorder	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release